Abstract
This chapter discusses a system biology approach to investigate the mechanism of cancer, especially the characteristic of the p53 pathway. Pathway modelling methods together with parameter estimation approaches are used to simulate the dynamic features of biological pathways. The core regulation part of the p53 pathway is analysed as an example, where its network motifs are identified by model selection methods based on the observation of experimental data. With the constructed mechanistic model, biological pathways can be simulated through in silicoexperiments to facilitate cancer research.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- MS:
-
Mass spectrometry
- Rb:
-
Retinoblastoma
- MMS:
-
Methyl methane sulfonate
- IR:
-
Ionising radiation
- MDM2:
-
Murine double minute 2
- GA:
-
Genetic algorithm
- EKF:
-
Extended Kalman filter
- UKF:
-
Unscented Kalman filter
- WRN:
-
Werner’s syndrome protein
- CHK1:
-
Serine/threonine-protein kinase
- SMC:
-
Sequential Monte Carlo
- CTMCs:
-
Continuous time Markov chains
- ODEs:
-
Ordinary differential equations
- SA:
-
Sensitivity analysis
References
Adams JM, Cory S (2002) Apoptosomes: engines for caspase activation. Curr Opin Cell Biol 14:715–720
Agarwal ML, Agarwal A, Taylor WR et al (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci 92:8493–8497
Alon U (2007a) An introduction to systems biology: design principles of biological circuits. CRC press, Boca Raton
Alon U (2007b) Network motifs: theory and experimental approaches. Nat Rev Genet 8:450–461
Anand P, Kunnumakkara AB, Sundaram C et al (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25:2097–2116
Appella E, Anderson CW (2001) Post‐translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268:2764–2772
Arisi I, Cattaneo A, Rosato V (2006) Parameter estimate of signal transduction pathways. BMC Neurosci 7:S6
Babu MM, Luscombe NM, Aravind L et al (2004) Structure and evolution of transcriptional regulatory networks. Curr Opin Struct Biol 14:283–291
Banin S, Moyal L, Shieh S et al (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677
Barkai N, Leibler S (1997) Robustness in simple biochemical networks. Nature 387:913–917
Batchelor E, Mock CS, Bhan I et al (2008) Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 30:277–289
Beaumont MA, Zhang W, Balding DJ (2002) Approximate Bayesian computation in population genetics. Genetics 162:2025–2035
Bhavsar P, Khorasani N, Hew M et al (2010) Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur Respir J 35:750–756
Burns TF, El‐Deiry WS (1999) The p53 pathway and apoptosis. J Cell Physiol 181:231–239
Calder M, Gilmore S, Hillston J et al (2010) Formal methods for biochemical signalling pathways. In: Boca PP, Bowen JP, Siddiqi JI (eds) Formal methods: state of the art and new directions. Springer, Dordrecht, pp 185–215
Cantley LC, Auger KR, Carpenter C et al (1991) Oncogenes and signal transduction. Cell 64:281–302
Cardelli L (2005) Brane calculi; interactions of biological membranes. Springer, Heidelberg, pp 257–278
Ciliberto A, Novak B, Tyson JJ (2005) Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 4:488–493
Ciocchetta F, Hillston J (2009) Bio-PEPA: a framework for the modelling and analysis of biological systems. Theor Comput Sci 410:3065–3084
Clarke E (1997) Model checking. Springer, Berlin/Heidelberg/New York, pp 54–56
Colman MS, Afshari CA, Barrett JC (2000) Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res Rev Mutat Res 462:179–188
Danos V, Krivine J (2004) Reversible communicating systems. In: Gardner P, Yoshida N (eds) CONCUR 2004-concurrency theory. Springer, Heidelberg, pp 292–307
Danos V, Laneve C (2004) Formal molecular biology. Theor Comput Sci 325:69–110
Donaldson R, Calde M (2010) Modelling and analysis of biochemical signalling pathway cross-talk. Arxiv preprint arXiv:1002.4062
Donaldson R, Gilbert D (2008) A model checking approach to the parameter estimation of biochemical pathways. Springer, Heidelberg, pp 269–287
Fey D, Findeisen R, Bullinger E (2008) Parameter estimation in kinetic reaction models using nonlinear observers facilitated by model extensions. In: International federation of automatic control. Seoul, Korea, pp 313–318
Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030–9040
Geva-Zatorsky N, Rosenfield N, Itzkovitz S et al (2006) Oscillations and variability in the p53 system. Mol Syst Biol 2:E1–E13
Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973–2983
Gilbert D, Heiner M, Lehrack S (2007) A unifying framework for modelling and analysing biochemical pathways using Petri nets. Springer, Heidelberg, pp 200–216
Gilbert D, Breitling R, Heiner M et al (2009) An introduction to biomodel engineering, illustrated for signal transduction pathways. Membr Comput 5391:13–28
Gillespie DT (1977) Exact stochastic simulation of coupled chemical reactions. J Phys Chem 81:2340–2361
Gilmore S, Hillston J (1994) The PEPA workbench: a tool to support a process algebra-based approach to performance modelling. In: Computer Performance Evaluation Modelling Techniques and Tools. Springer, Vienna, p 353–368
Goldbeter A, Berridge M, Cambridge University Press (1996) Biochemical oscillations and cellular rhythms: the molecular bases of periodic and chaotic behaviour. Cambridge University Press, New York
Green DR, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127–1130
Gudkov AV, Komarova EA (2003) The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3:117–129
Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899–2908
Hendriks BS, Hua F, Chabot JR (2008) Analysis of mechanistic pathway models in drug discovery: p38 pathway. Biotechnol Prog 24:96–109
Herlaar E, Brown Z (1999) p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:439–447
Hermeking H, Lengauer C, Polyak K et al (1997) 14-3-3 [sigma] is a p53-regulated inhibitor of G2/M progression. Mol Cell 1:3–11
Hoare CAR (1981) A calculus of total correctness for communicating processes. Sci Compu Program 1:49–72
Hollstein M, Sidransky D, Vgelstein B et al (1991) p53 mutations in human cancers. Science 253:49–53
Isobe M, Emanuel BS, Givol D et al (1986) Localization of gene for human p53 tumour antigen to band 17p13. Nature 320:84–85
Jeffreys H (1935) Some tests of significance, treated by the theory of probability. Cambridge University Press, Cambridge, pp 203–222
Jia J, Yue H (2009) Sensitivity analysis and parameter estimation of signal transduction pathways model. Asian Control Conference, Hong Kong, China. IEEE, pp. 1357–1362
Jin S, Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139–4140
Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90:773–795
Kastan MB, Zhang D, El-Deiry WS et al (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597
Kern SE, Kinzler JW, Bruskin A et al (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711
Kitano H (2002) Computational systems biology. Nature 420:206–210
Kitano H (2004) Biological robustness. Nat Rev Genet 5:826–837
Klipp E, Liebermeister W (2006) Mathematical modeling of intracellular signaling pathways. BMC Neurosci 7:S10
Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci 90:10914–10921
Koch I (2010) Modeling in systems biology: the Petri Net approach. Springer, New York
Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s–1700s
Kubbutat MHG, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387:299–303
Lahav G, Rosenfield N, Sigal A et al (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36:147–150
Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18:7644–7655
Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16
Lev Bar-Or R, Maya R, Segal LA et al (2000) Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci 97:11250–11255
Levine AJ (1997) p53, the cellular gatekeeper review for growth and division. Cell 88:323–331
Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13:1027–1036
Li Y, Agarwal P, Rajagopalan D (2008) A global pathway crosstalk network. Bioinformatics 24:1442–1447
Lillacci G, Khammash M (2010) Parameter estimation and model selection in computational biology. PLoS Comput Biol 6:e1000696
Lipshtat A, Purushothaman SP, Iyengar R et al (2008) Functions of bifans in context of multiple regulatory motifs in signaling networks. Biophys J 94:2566–2579
Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression. Nature 432:307–315
Macleod K (2000) Tumor suppressor genes. Curr Opin Genet Dev 10:81–93
Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238
Mangan S, Alon U (2003) Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci USA 100:1980–1985
Marjoram P, Tavaré S (2006) Modern computational approaches for analysing molecular genetic variation data. Nat Rev Genet 7:759–770
Matlashewski G, Lamb P, Pim D et al (1984) Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J 3:3257–3262
McBride O, Merry D, Givol D (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci 83:130–134
Meek DW (2004) The p53 response to DNA damage. DNA Repair 3:1049–1056
Mihalcescu I, Hsing W, Leibler S (2004) Resilient circadian oscillator revealed in individual cyanobacteria. Nature 430:81–85
Milner R (1989) Communication and concurrency. Prentice-Hall, New York
Milo R, Shen-Orr S, Itzkovitz S et al (2002) Network motifs: simple building blocks of complex networks. Science 298:824–827
Moles CG, Mendes P, Banga JR (2003) Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome Res 13:2467–2474
Momand J, Wu HH, Dasgupta G (2000) MDM2–master regulator of the p53 tumor suppressor protein. Gene 242:15–29
Nigro JM, Baker SJ, Preisinger AC et al (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705–708
Novak B, Tyson JJ (1993) Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J Cell Sci 106:1153–1168
Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10:431–442
Overholtzer M, Rao PH, Favis R et al (2003) The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA 100:11547–11552
Pomerening JR, Sontag ED, Ferrell JE (2003) Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat Cell Biol 5:346–351
Priami C (1995) Stochastic-calculus. Comput J 38:578–589
Prill RJ, Iglesias PA, Levchenko A (2005) Dynamic properties of network motifs contribute to biological network organization. PLoS Biol 3:e343
Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112–126
Proctor C, Gray D (2008) Explaining oscillations and variability in the p53-Mdm2 system. BMC Syst Biol 2:75
Quach M, Brunel N, d’Alché-Buc F (2007) Estimating parameters and hidden variables in non-linear state-space models based on ODEs for biological networks inference. Bioinformatics 23:3209–3212
Regev A, Panina EM, Silverman W et al (2004) BioAmbients: an abstraction for biological compartments. Theor Comput Sci 325:141–167
Reich N, Oren M, Levine A (1983) Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 3:2143–2150
Ribeiro D, Pinto JM (2009) An integrated network-based mechanistic model for tumor growth dynamics under drug administration. Comput Biol Med 3:368–384
Riley T, Sontag E, Chen P et al (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9:402–412
Rozan L, El-Deiry W (2006) p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ 14:3–9
Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13:332–337
Sax J, El-Deiry W (2003) p53 downstream targets and chemosensitivity. Cell Death Differ 10:413–417
Schneider K (2012) Counseling about cancer: strategies for genetic counseling. Wiley-Blackwell, Hoboken
Shen-Orr SS, Milo R, Mangan S et al (2002) Network motifs in the transcriptional regulation network of Escherichia coli. Nat Genet 31:64–68
Sherr CJ (2004) Principles of tumor suppression. Cell 116:235–246
Sisson SA, Fan Y, Tanaka MM (2007) Sequential Monte Carlo without likelihoods. Proc Natl Acad Sci 104:1760–1765
Srinivas M, Patnaik LM (1994) Genetic algorithms: a survey. Computer 27:7–26
Sun X, Jin L, Xiong M (2008) Extended Kalman filter for estimation of parameters in nonlinear state-space models of biochemical networks. PLoS One 3:e3758
Thron C (1996) A model for a bistable biochemical trigger of mitosis. Biophys Chem 57:239–251
Toni T, Welch D, Strelkowa N et al (2009) Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems. J R Soc Interface 6:187–202
Tyson J (2002) Biochemical oscillations. In: Computational cell biology. Springer, New York, pp 230–260
Tyson JJ, Chen KC, Novak B (2003) Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15:221–231
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275–283
Wade Harper J, Adami GR, Wei N et al (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816
Wood RD, Mitchell M, Sgours J et al (2001) Human DNA repair genes. Science 291:1284–1289
Yaffe MB (2008) Signaling networks and mathematics. Sci Signal 1(143):eg7
Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26:1317–1322
Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851–858
Zambetti GP (2005) The p53 tumor suppressor pathway and cancer. Springer, New York
Zilfou JT, Lowe SW (2009) Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1(15)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Guo, Y., Yang, X. (2012). System Biology Approach to Study Cancer Related Pathways. In: Azmi, A.S. (eds) Systems Biology in Cancer Research and Drug Discovery. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4819-4_2
Download citation
DOI: https://doi.org/10.1007/978-94-007-4819-4_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4818-7
Online ISBN: 978-94-007-4819-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)